Showing results (1301-1310 of 1,497) with videos related to

Sort By:
Pageof 150
Stroke|February 27, 2010
Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trialE Clarke Haley, John L P Thompson, James C Grotta, et al.
Arthritis and Rheumatism|June 17, 2000
The use of alternative medical therapies in patients with systemic lupus erythematosus. Trination Study GroupA D Moore, M A Petri, S Manzi, et al.
The Journal of Rheumatology|November 16, 2001
Living with lupus: a prospective pan-Canadian studyP L Dobkin, D Da Costa, P R Fortin, et al.
Lupus|June 10, 2017
Breast cancer in systemic lupus erythematosus (SLE): receptor status and treatmentK Chan, A E Clarke, R Ramsey-Goldman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 4, 2026
Increased Risk of Intrahepatic Cholestasis of Pregnancy in SLE Women Exposed to AzathioprineReem Farhat, Maria Del Carmen Zamora-Medina, Sang-Cheol Bae, et al.
Arthritis and Rheumatism|February 3, 2007
The systemic lupus erythematosus Tri-Nation study: cumulative indirect costsPantelis Panopalis, Michelle Petri, Susan Manzi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
Identification of a New Susceptibility Locus for Systemic Lupus Erythematosus on Chromosome 12 in Individuals of European AncestryF Yesim Demirci, Xingbin Wang, Jennifer A Kelly, et al.
Arthritis Research & Therapy|July 7, 2018
Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelinesApril M Jorge, Ronald B Melles, Yuqing Zhang, et al.
British Journal of Pharmacology|June 16, 1999
In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonistsT J Williams, D R Blue, D V Daniels, et al.
Rheumatology (Oxford, England)|March 11, 2005
The systemic lupus erythematosus tri-nation study: longitudinal changes in physical and mental well-beingP Panopalis, M Petri, S Manzi, et al.
Pageof 150